salvinorin a has been researched along with enkephalin, ala(2)-mephe(4)-gly(5)- in 10 studies
Studies (salvinorin a) | Trials (salvinorin a) | Recent Studies (post-2010) (salvinorin a) | Studies (enkephalin, ala(2)-mephe(4)-gly(5)-) | Trials (enkephalin, ala(2)-mephe(4)-gly(5)-) | Recent Studies (post-2010) (enkephalin, ala(2)-mephe(4)-gly(5)-) |
---|---|---|---|---|---|
247 | 7 | 128 | 151 | 0 | 71 |
247 | 7 | 128 | 2,727 | 1 | 374 |
Protein | Taxonomy | salvinorin a (IC50) | enkephalin, ala(2)-mephe(4)-gly(5)- (IC50) |
---|---|---|---|
Muscarinic acetylcholine receptor M1 | Rattus norvegicus (Norway rat) | 0.003 | |
Muscarinic acetylcholine receptor M3 | Rattus norvegicus (Norway rat) | 0.003 | |
Muscarinic acetylcholine receptor M4 | Rattus norvegicus (Norway rat) | 0.003 | |
Muscarinic acetylcholine receptor M5 | Rattus norvegicus (Norway rat) | 0.003 | |
Muscarinic acetylcholine receptor M2 | Rattus norvegicus (Norway rat) | 0.003 | |
Delta-type opioid receptor | Mus musculus (house mouse) | 1.2415 | |
Mu-type opioid receptor | Rattus norvegicus (Norway rat) | 0.0132 | |
Mu-type opioid receptor | Homo sapiens (human) | 0.004 | |
Delta-type opioid receptor | Homo sapiens (human) | 0.0014 | |
Mu-type opioid receptor | Mus musculus (house mouse) | 0.0048 | |
Mu-type opioid receptor | Cavia porcellus (domestic guinea pig) | 0.0283 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (40.00) | 29.6817 |
2010's | 5 (50.00) | 24.3611 |
2020's | 1 (10.00) | 2.80 |
Authors | Studies |
---|---|
Bohn, LM; Dersch, CM; Groer, CE; Harding, WW; Hiemstra, J; Lozama, A; Marquam, A; Partilla, JS; Prisinzano, TE; Rothman, RB; Schmidt, M; Tidgewell, K | 1 |
Azar, MR; Cashman, JR; Ghirmai, S | 1 |
Ferreira, D; Polepally, PR; Roth, BL; Vardy, E; White, K; Zjawiony, JK | 1 |
Huben, K; Mosier, PD; Polepally, PR; Roth, BL; Setola, V; Vardy, E; Zjawiony, JK | 1 |
Fujii, H; Hirayama, S; Hirono, S; Iwai, T; Kuroda, N; Nagase, H; Wada, N; Yamaotsu, N | 1 |
Biscaia, M; Crowley, RS; Filizola, M; Groer, CE; Kivell, BM; Paton, K; Prisinzano, TE; Provasi, D; Riley, AP; Schneider, S; Sherwood, AM; Shivaperumal, N | 1 |
Bow, E; Crowley, R; Deschamps, JR; Gutman, ES; Hassan, SA; Imler, GH; Jacobson, AE; Kaska, S; Lee, YS; Li, F; Prisinzano, TE; Rice, KC; Sulima, A | 1 |
Dersch, CM; Godin, JA; Murphy, DL; Partilla, JS; Prisinzano, TE; Rothman, RB; Schmidt, M; Tidgewell, K; Xu, H | 1 |
Benaderet, TS; Bishop-Mathis, K; Dersch, CM; Partilla, JS; Prisinzano, TE; Rothman, RB; Simpson, DS; Wang, X; Xu, H | 1 |
Bartuzi, D; Kaczor, AA; Matosiuk, D | 1 |
10 other study(ies) available for salvinorin a and enkephalin, ala(2)-mephe(4)-gly(5)-
Article | Year |
---|---|
Herkinorin analogues with differential beta-arrestin-2 interactions.
Topics: Arrestins; beta-Arrestin 2; beta-Arrestins; Cell Line; Diterpenes; Diterpenes, Clerodane; Humans; Magnetic Resonance Spectroscopy; Mass Spectrometry; Radioligand Assay; Receptors, Opioid, kappa; Receptors, Opioid, mu | 2008 |
Synthesis and pharmacological evaluation of 6-naltrexamine analogs for alcohol cessation.
Topics: Alcohol Deterrents; Alcoholism; Animals; Humans; Liver; Male; Mice; Naltrexone; Nociceptin Receptor; Protein Binding; Rats; Rats, Wistar; Receptors, Opioid; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu; Structure-Activity Relationship | 2009 |
Kappa-opioid receptor-selective dicarboxylic ester-derived salvinorin A ligands.
Topics: Camphanes; Diterpenes, Clerodane; Dose-Response Relationship, Drug; Drugs, Chinese Herbal; HEK293 Cells; Humans; Molecular Conformation; Panax notoginseng; Receptors, Opioid, kappa; Salvia; Salvia miltiorrhiza; Structure-Activity Relationship | 2013 |
Michael acceptor approach to the design of new salvinorin A-based high affinity ligands for the kappa-opioid receptor.
Topics: Diterpenes, Clerodane; Drug Design; HEK293 Cells; Humans; Ligands; Models, Molecular; Protein Binding; Protein Conformation; Receptors, Opioid, kappa | 2014 |
Synthesis of a novel universal opioid receptor agonist with the 1,3,5-trioxazatriquinane skeleton and its pharmacologies.
Topics: Animals; Dose-Response Relationship, Drug; Guinea Pigs; Heterocyclic Compounds, 4 or More Rings; Humans; Mice; Molecular Conformation; Receptors, Opioid, kappa; Structure-Activity Relationship | 2014 |
Synthetic Studies of Neoclerodane Diterpenes from Salvia divinorum: Identification of a Potent and Centrally Acting μ Opioid Analgesic with Reduced Abuse Liability.
Topics: Analgesics, Opioid; Animals; Cells, Cultured; CHO Cells; Cricetulus; Diterpenes; Diterpenes, Clerodane; Dose-Response Relationship, Drug; Male; Molecular Structure; Pain; Pain Measurement; Rats; Rats, Sprague-Dawley; Receptors, Opioid, mu; Salvia; Structure-Activity Relationship | 2016 |
G-Protein biased opioid agonists: 3-hydroxy-
Topics: | 2020 |
Salvinorin A: allosteric interactions at the mu-opioid receptor.
Topics: Allosteric Regulation; Animals; CHO Cells; Cricetinae; Cricetulus; Cyclic AMP; Diprenorphine; Diterpenes; Diterpenes, Clerodane; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Guanosine 5'-O-(3-Thiotriphosphate); Humans; Kinetics; Morphinans; Receptors, Opioid, kappa; Receptors, Opioid, mu | 2007 |
Differential effects of opioid agonists on G protein expression in CHO cells expressing cloned human opioid receptors.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Analgesics, Opioid; Animals; Benzamides; Blotting, Western; CHO Cells; Cricetinae; Cricetulus; Diterpenes, Clerodane; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalin, D-Penicillamine (2,5)-; Enkephalin, Leucine-2-Alanine; Ethylketocyclazocine; Etorphine; Female; Furans; Gene Expression; GTP-Binding Protein alpha Subunits, G12-G13; GTP-Binding Protein alpha Subunits, Gi-Go; Humans; Morphine; Oligopeptides; Piperazines; Pyrones; Receptors, Opioid; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu | 2008 |
Activation and Allosteric Modulation of Human μ Opioid Receptor in Molecular Dynamics.
Topics: Allosteric Regulation; Allosteric Site; Diterpenes, Clerodane; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Furans; Humans; Ligands; Molecular Docking Simulation; Molecular Dynamics Simulation; Morphine; Pyrones; Receptors, Opioid, mu; Salvia | 2015 |